COMPLERA
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fu…
- Strength
- 200 mg/1, 25 mg/1, 300 mg/1
- Form
- Tablet, Film Coated
- Class
- Hepatitis B Virus Nucleoside Analog Rev…
Gilead Sciences, Inc.
Not stocked by us — reference only
Listed by Cipla USA Inc.
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 69097-642 |
| FDA application | ANDA091168 |
| RxNorm concept | 403875 |
| Package sizes listed | 2 |
| Marketed since | August 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fu…
Gilead Sciences, Inc.
Not stocked by us — reference only
emtricitabine and tenofovir alafenamide
Gilead Sciences, Inc.
Not stocked by us — reference only
emtricitabine and tenofovir alafenamide
Gilead Sciences, Inc.
Not stocked by us — reference only
Aurobindo Pharma Limited
Not stocked by us — reference only
Aurobindo Pharma Limited
Not stocked by us — reference only
NuCare Pharmaceuticals, Inc.
Not stocked by us — reference only
Amneal Pharmaceuticals NY LLC
Not stocked by us — reference only
Zydus Lifesciences Limited
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.